LBA57Overall survival results of ceritinib in ALKi-naïve patients with ALK-rearranged NSCLC (ASCEND-3). (23rd October 2018) - Felip, E; Nishio, M; Orlov, S; Park, K; Yu, C-J; Tsai, C-M; Cobo, M; McKeage, M; Su, W-C; SK Mok, T; Scagliotti, G V; Spigel, D; et al.